In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Circulation
; 141(1): 67-79, 2020 01 07.
Article
in En
| MEDLINE
| ID: mdl-31779484
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dependovirus
/
Atherosclerosis
/
CRISPR-Cas Systems
/
Gene Editing
/
Hyperlipoproteinemia Type II
Limits:
Animals
Language:
En
Journal:
Circulation
Year:
2020
Type:
Article